Jeffrey Epstein, George Church, nicotine: Morning Rounds
Receive your daily dose of health and medicine updates every weekday by subscribing to STAT’s free newsletter Morning Rounds. Stay informed with the latest news and insights in the world of healthcare.
Good morning! In the realm of journalism, recent discussions about AI have been unsettling. However, it’s important to note that all of STAT’s journalism, including this newsletter, is crafted by human reporters. Our commitment to accuracy and integrity remains unwavering.
A New Mystery Unfolds: Epstein’s Role in Harvard Genetics Study
The discovery of alterations made to Jeffrey Epstein’s profile on the Personal Genome Project’s public page has raised eyebrows. Despite Epstein’s passing in 2019, changes were observed on his profile in 2026, sparking intrigue. Investigative journalist Megan Molteni delves into the details, shedding light on the enigmatic connection between Epstein and the genetics study.
Chile Achieves a Milestone in Leprosy Elimination
Celebrations abound as Chile becomes the first country in the Americas and the second globally to be verified by the World Health Organization for eliminating leprosy. A testament to Chile’s proactive approach to healthcare, this achievement marks a significant milestone in the fight against the ancient disease.
TrumpRx: A Month In, Questions Linger
President Trump’s drug discount platform, TrumpRx, has garnered attention since its launch. However, a month into its operation, uncertainties loom regarding its efficacy and accessibility. As the platform navigates the complexities of healthcare economics, its true impact remains to be seen.
Pediatric Nicotine Exposure Trends Evolve
A recent study published in JAMA Network Open highlights shifting trends in pediatric nicotine exposure. With a surge in e-cigarette-related incidents and a decline in traditional tobacco exposures, the landscape of nicotine ingestion among children has transformed. The study underscores the importance of monitoring evolving patterns in nicotine consumption.
Exploring the Link Between GLP-1s and Addiction
Emerging evidence suggests a potential connection between GLP-1 drugs and reduced substance-related harm. Physician-researcher Ziyad Al-Aly discusses the findings of a recent study, shedding light on the intriguing relationship between diabetes medication and addiction outcomes. The study opens new avenues for research into the therapeutic potential of GLP-1s.
In Conclusion
Stay informed with the latest healthcare updates and insights by subscribing to Morning Rounds. From groundbreaking research to global health milestones, STAT’s newsletter delivers a comprehensive overview of the ever-evolving landscape of medicine and science. Sign up today to start your day with a dose of health and wellness.
